Pediatric Cancers
 

Your access to vital information on pediatric cancers is now easier, with comprehensive coverage of this topic at your fingertips. ASCO has gathered and synthesized data on pediatric cancers from a multitude of key sources, including the Journal of Clinical Oncology and other ASCO publications, the Virtual Meeting, and more. Experience the ease of finding in-depth information on pediatric cancers topics, and visit often to remain current with timely updates.

  

 
JCO Highlighted Pediatric Cancers Articles Last Updated: May 29, 2009
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study (JCO, March 2009)
Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without MYCN Gene Amplification (JCO, March 2009)
Iodine-131?Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study (JCO, March 2009)
Soft Tissue Sarcomas of Childhood and Adolescence: The Prognostic Role of Tumor Size in Relation to Patient Body Size (JCO, January 2009)
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group (JCO, January 2009)

More >
Medline Latest Pediatric Cancers Articles Last Updated: June 28, 2009
Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. (J Clin Oncol, 2009 Apr)
Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience. (J Clin Oncol, 2009 May)
Prospective validation of a prognostic score to improve patient selection for oncology phase I trials. (J Clin Oncol, 2009 Mar)
Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. (Lancet Oncol, 2009 May)
Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial. (Lancet Oncol, 2009 May)

More >
Virtual Meeting  

Select Presentations from the 2009 ASCO Annual Meeting

More >
Abstracts  

Abstracts from the 2008 ASCO Annual Meeting

Search the 2008 pediatric cancer abstracts as well as abstracts back through the 2000 Annual Meeting

More >
Educational Book  

Manuscripts from the 2009 Educational Book

Find pediatric cancer manuscripts grouped into areas of interest, or search the 2002-2009 Educational Books archive.

More >
Cancer.Net  

Cancer.Net doctor-approved cancer information from ASCO

Find information and resources to support your pediatric patients living with cancer

More >
 
 
2009 ASCO Annual Meeting
ASCO Annual Meeting 2009
Orlando Convention Center
May 29 - June 2

Highlights